VolitionRx Limited (VNRX)
NYSEAMERICAN: VNRX · Real-Time Price · USD
1.280
-0.120 (-8.57%)
At close: Jul 8, 2026, 4:00 PM EDT
1.345
+0.065 (5.08%)
After-hours: Jul 8, 2026, 8:00 PM EDT

VolitionRx Stock Forecast

VNRX's stock price has decreased by -90.5% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 5 analysts polled by S&P Global, VolitionRx stock has a consensus rating of "Buy" and an average price target of $16.97. The average 1-year stock price forecast is 1,225.78% higher than the current stock price, while the lowest is $4.00 (+212.50%) and the highest is $24 (+1,775.00%).

Price Target: $16.97 (+1,225.78%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$4.00$16.97$20$24
Change+212.50%+1225.8%+1462.5%+1775.0%

Analyst Ratings

The average analyst rating for VolitionRx stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy444333
Buy000001
Hold211211
Sell000000
Strong Sell000000
Total655545

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Maxim Group
Maxim Group
Buy
Initiates
$4
BuyInitiates$4+212.50%Jun 18, 2026
JonesTrading
JonesTrading
Buy
Reiterates
$3$24
BuyReiterates$3$24+1,775.00%May 19, 2026
D. Boral Capital
D. Boral Capital
Hold
Downgrades
n/a
HoldDowngradesn/an/aApr 20, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$20
BuyReiterates$20+1,462.50%Apr 2, 2026

Financial Forecast

Revenue This Year
2.48M
from 1.73M
Increased by 43.43%
Revenue Next Year
5.73M
from 2.48M
Increased by 131.40%
EPS This Year
-2.62
from -4.40
EPS Next Year
-1.15
from -2.62
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
90.04K306.39K775.30K1.23M1.73M2.48M
Revenue Growth
570.25%240.30%153.04%59.10%40.04%43.43%
Gross Profit
90.04K306.39K775.30K1.23M1.73M2.11M
Gross Margin
100.00%100.00%100.00%100.00%100.00%85.10%
Operating Income
-28.33M-31.78M-35.99M-27.02M-21.74M-20.09M
Net Income
-26.81M-30.27M-35.32M-26.97M-23.36M-22.20M
EPS
-----4.40-2.62
Free Cash Flow
-12.68M-6.61M-28.37M-15.56M-8.52M-16.18M
No. Analysts
-----6
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High2.9M
Avg2.5M
Low2.0M

Revenue Growth

Revenue Growth202620272028
High
69.0%
Avg
43.4%
Low
17.1%

EPS Forecast

EPS202620272028
High-2.62
Avg-2.62
Low-2.62

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-